Stay updated with breaking news from Informa Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite the prevalence and societal costs of pain in the United States, investment in pain medication development is low, due in part to poor understanding of the probability of successful development of such medications
New brand name Citeline reflects company transformation to focus on the global future of pharmaceutical and biopharmaceutical researchLONDON and NEW YORK, June 22, 2022. The rebrand follows leading global
Investegate announcements from Pharma Intelligence, Pharma Intelligence Unveils Its Rebrand to Citeline Following Transition to Independent Company
Rezolute faced a challenging task— to recruit pediatric patients for a clinical trial of an ultra-rare disease. In addition, Rezolute wanted to...
The psychedelic industry could revolutionize mental healthcare. Compounds like MDMA and psilocybin are rapidly being pushed through clinical trials and have already been embraced by numerous cities and states across the US. With the psychedelics gold rush upon us, experts are warning about the need for marketers to prioritize sober education over intoxicating profit.